10 results about "Eye infection" patented technology

Embodiments of the present invention generally relate to novel immunostimulatory compositions of use to stimulate non-specific immune responses in a subject. In certain embodiments, immunogenic compositions disclosed herein can be directed to use in the eye of a subject. In some embodiments, the immunogenic compositions disclosed herein enhance non-specific immune responses in the eye of a subject to treat or reduce the risk of onset of an eye condition. In other embodiments, compositions disclosed herein can be used to treat eye infections due to a microorganism, tumors of the eye, as well as, chronic wounds or infections of the eye. In some embodiments, immunogenic ocular formulations disclosed herein include combinations of agents for prolonged exposure to the eye for improved outcomes.

The present invention relates to an ophthalmic composition in the form of an aqueous solution containing levofloxacin or salt or derivative thereof and ketorolac or salt or derivative. The present invention relates to an ophthalmic composition in the form of an aqueous solution containing levofloxacin or salt or derivative thereof and ketorolac or salt or derivative thereof, for use in a method for the treatment of conjunctivitis and for the prevention or treatment of inflammation or prevention of infection after cataract surgery in a subject, according to a dosage regimen that improves patient compliance and tolerability and enables the prevention and treatment of intermediate / antibiotic-resistant infections.

A method of treating an eye disorder in a patient that may include administering a medicament to the patient with a prefilled syringe, wherein the administration of the medicament with the prefilled syringe is configured to treat the eye disorder and decrease a rate of likelihood of an ocular infection to the patient's eye.

The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.

The application discloses an intelligent glasses system for regulating and maintaining eyesight and a use method thereof, and relates to the technical field of smart wearable devices.The application comprises a frame and a temple, and further comprises the following modules: a main control module for processing data and coordinating the operation of each module; a line-of-sight tracking and depth estimation module for determining the eye fixation position and distance; and a posture detection module.The application realizes comprehensive monitoring and intervention of the user's eye behavior by integrating multi-modal sensors and intelligent algorithms.The system simultaneously covers eye distance regulation, bad posture recognition, electronic device usage time management and eye hygiene reminders, solves the problem of single function of the prior art, and through the line-of-sight tracking and depth estimation module, the user's position for looking near or looking far is determined in real time, and in combination with posture detection, device usage detection and eye contact detection, myopia, hyperopia, visual fatigue and eye infections and various abnormal vision conditions are prevented from multiple dimensions, and the original vision protection effect is improved.

The application discloses a pathogen detection primer group, a kit and application in pathogen detection of eye infection, the detection primer group contains 162 pairs of primers for 54 pathogenic microorganisms, interference competition between each primer is small, and one pair of primers is selected for each pathogenic microorganism, so that the detection of the 54 pathogenic microorganisms can be realized simultaneously, when all the 162 pairs of primers are selected, the sensitivity and specificity of species identification can be improved, specific identification to species and high-sensitivity detection of bacteria, fungi, viruses and parasites can be realized, and the requirement of precise clinical diagnosis can be met.

To provide an ophthalmic system capable of surely preventing nosocomial infection such as ophthalmic infectious disease.SOLUTION: The ophthalmic system 1 includes a face image capture device 10 installed at a hospital entrance and an terminal 20 installed in the hospital. The face imaging device 10 includes an imaging unit 11 that captures a face image Q of a patient P, a detection unit 12 that detects a sign of an eye disorder from the face image Q, a communication unit 14 that transmits and receives information to and from the terminal 20, and an instruction notification unit 15 that notifies the patient P of an instruction S from the terminal 20. The communication unit 14 transmits the face image Q to the terminal 20 at least when there is a sign of an eye disorder. When the presence or absence of an eye disorder is determined on the terminal 20 side, the instruction S is transmitted to the instruction notification unit 15, and the instruction notification unit 15 notifies the patient P of an action based on the instruction S.SELECTED DRAWING: Figure 3

The application discloses a capsid protein mutant capable of improving the whole-eye infection ability of an AAV virus and an application thereof. The inventors have found that the whole-eye infection ability of an AAV virus can be effectively improved by using a specific peptide to replace amino acids at positions 561 to 588 of a wild-type AAV2 virus capsid protein, and the problem of the infection efficiency of AAV2 on eyes is fundamentally solved.

The invention discloses a primer probe combination for simultaneously detecting AMB, VZV and HSV-1 as well as a detection method, application and a product of the primer probe combination, and belongs to the technical field of molecular biological detection. The technical problems to be solved are that an existing eye infection detection technology cannot synchronously detect AMB, VZV and HSV-1 in a single tube, or only covers viruses and misses AMB, or needs multi-tube operation, is fuzzy in identification, insufficient in sensitivity, difficult to adapt to eye trace samples, and cannot meet clinical rapid and accurate diagnosis requirements. According to the technical scheme, the method is characterized in that specific primer probes aiming at 18S rRNA genes of AMB, ORF62 genes of VZV and UL30 genes of HSV-1 are provided and matched with internal quality control primer probes, four different fluorescence labels are adopted, a single-tube multiple real-time fluorescent PCR detection method is established, a matched kit is prepared, and synchronous detection and identification of three pathogens are achieved. The kit is high in sensitivity and strong in specificity and anti-interference capability.